Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-24 Sale | 2025-03-26 4:47 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $50 | $300,000 | 877,741 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 10,565 | $47.88 | $505,856 | 65,057 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 7,583 | $47.89 | $363,142 | 79,682 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 9,686 | $47.88 | $463,766 | 51,712 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 6,711 | $47.88 | $321,323 | 46,355 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 24,216 | $48.03 | $1,163,050 | 883,741 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 3,724 | $47.88 | $178,306 | 22,431 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:34 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 35,000 | $26.08 | $912,961 | 279,552 (Indirect Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:26 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 10,445 | $27.47 | $286,924 | 101,780 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-17 Exercise | 2025-03-18 9:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 16,038 | $0 | 50,215 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 102,790 | $0 | 1,022,571 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 37,770 | $0 | 93,553 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 38,426 | $0 | 102,212 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 42,528 | $0 | 132,718 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:38 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 41,914 | $0 | 120,768 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:01 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 7,000 | $0 | 13,350 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:01 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 7,000 | $12.89 | 13,350 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:20 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 55,789 | $0 | 55,789 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:18 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:17 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 150,248 | $0 | 150,248 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:17 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 25,359 | $0 | 25,359 (Direct) | View |
| 2024-11-13 Option Award | 2024-11-15 4:37 pm | N/A 2034-11-12 | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 16,700 | $0 | 16,700 (Direct) | View |
| 2024-11-04 Option Award | 2024-11-06 4:40 pm | N/A 2034-11-03 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 68,352 | $0 | 68,352 (Direct) | View |
| 2024-09-30 Gift | 2024-10-02 5:27 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 6,016 | $0 | 6,016 (Direct) | View |
| 2024-09-15 Exercise | 2024-09-17 5:52 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 1,333 | $0 | 7,350 (Direct) | View |
| 2024-08-12 Other | 2024-08-14 4:34 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 112,454 | $0 | 279,552 (Indirect) | View |
| 2024-06-24 Exercise | 2024-06-25 6:26 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director | 3,350 | $0 | 5,350 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:26 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 3,350 | $0 | 6,350 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:25 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 3,350 | $0 | 139,982 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:24 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director | 3,350 | $0 | 33,256 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:23 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 3,350 | $0 | 4,683 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:22 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 3,350 | $0 | 5,350 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:21 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 3,350 | $0 | 10,350 (Direct) | View |
| 2024-06-17 Exercise | 2024-06-20 4:26 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 27,881 | $0 | 101,780 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:45 pm | N/A 2034-06-12 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 8,350 | $0 | 8,350 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:44 pm | N/A 2034-06-12 | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 8,350 | $0 | 8,350 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:40 pm | N/A 2034-06-12 | Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director | 8,350 | $0 | 8,350 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:38 pm | N/A 2034-06-12 | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 8,350 | $0 | 8,350 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:33 pm | N/A 2034-06-12 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director | 8,350 | $0 | 8,350 (Direct) | View |